Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2026-02-03 @ 1:18 PM
Study NCT ID:
NCT02569632
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2015-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
Sponsor:
UCSF Benioff Children's Hospital Oakland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-30
First Submit QC Date:
None
Study First Post Date:
2015-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-10
Results First Submit QC Date:
None
Results First Post Date:
2021-02-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-01
Last Update Post Date:
2021-02-02
Last Update Post Date Type:
ACTUAL